Polynucleotide-based "skin boosters" — sometimes circulating under viral nicknames — are one of the buzziest injectable categories around, with real and rising patient demand. They also come with a significant US regulatory catch, and the gap between the two is exactly where practices get into trouble. Patients are asking for it by its trendy name; whether you can legally offer the specific products as marketed is the question the hype skips.
This is general education for owners, not medical or legal advice.